Shefali Agarwal

(Dr. Shefali Agarwal)

Currently holds a position at Fate Therapeutics Inc

Positions
Position Company Period
Director Fate Therapeutics Inc July 15, 2019 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-06-08 2022-06-07
S Sale
841 -31.4%
21.89
18,409 USD 		841 -31.4% 21.89 18,409 USD
2022-06-06 2022-06-03
S Sale
807 -30.1%
22.80
18,400 USD 		807 -30.1% 22.80 18,400 USD
2022-02-09 2022-02-07
US Epizyme Inc (EPZM)
PS Planned sale
1,058 -0.7%
1.50
1,587 USD 		1,058 -0.7% 1.50 1,587 USD
2022-02-04 2022-02-02
US Epizyme Inc (EPZM)
PS Planned sale
2,639 -1.6%
1.37
3,615 USD 		2,639 -1.6% 1.37 3,615 USD
2022-01-28 2022-01-26
US Epizyme Inc (EPZM)
PS Planned sale
2,922 -1.8%
2.02
5,902 USD 		2,922 -1.8% 2.02 5,902 USD
2021-12-07 2021-12-06
US Epizyme Inc (EPZM)
PS Planned sale
1,780 -1.1%
2.93
5,215 USD 		1,780 -1.1% 2.93 5,215 USD
2021-02-05 2021-02-04
US Epizyme Inc (EPZM)
PS Planned sale
969 -0.9%
11.21
10,862 USD 		969 -0.9% 11.21 10,862 USD
2021-01-27 2021-01-25
US Epizyme Inc (EPZM)
PS Planned sale
2,872 -3.7%
11.41
32,770 USD 		2,872 -3.7% 11.41 32,770 USD
2020-12-07 2020-12-03
US Epizyme Inc (EPZM)
PS Planned sale
2,522 -3.2%
13.54
34,148 USD 		2,522 -3.2% 13.54 34,148 USD
2020-03-26 2020-03-25
US Epizyme Inc (EPZM)
PS Planned sale
1,243 -1.7%
15.28
18,993 USD 		1,243 -1.7% 15.28 18,993 USD
2020-01-27 2020-01-27
US Epizyme Inc (EPZM)
PS Planned sale
2,630 -4.3%
20.44
53,757 USD 		2,630 -4.3% 20.44 53,757 USD
2020-01-27 2020-01-24
US Epizyme Inc (EPZM)
PS Planned sale
1,843 -2.9%
24.64
45,412 USD 		1,843 -2.9% 24.64 45,412 USD
2019-06-17 2019-06-14
US Epizyme Inc (EPZM)
PS Planned sale
1,195 -3.2%
11.97
14,304 USD 		1,195 -3.2% 11.97 14,304 USD